主页 文献库文献详情
PMID: 24299561 已发表 · epublish 英语

Integrated molecular portrait of non-small cell lung cancers.

BMC medical genomics ·第 6 卷 ·2014-06-25

Lazar Vladimir, Suo Chen, Orear Cedric, van den Oord Joost, Balogh Zsofia, Guegan Justine, Job Bastien, Meurice Guillaume, Ripoche Hugues, Calza Stefano, Hasmats Johanna, Lundeberg Joakim, Lacroix Ludovic, Vielh Philippe, Dufour Fabienne, Lehtiö Janne, Napieralski Rudolf, Eggermont Alexander, Schmitt Manfred, Cadranel Jacques, Besse Benjamin, Girard Philippe, Blackhall Fiona, Validire Pierre, Soria Jean-Charles, Dessen Philippe, Hansson Johan, Pawitan Yudi

摘要

Non-small cell lung cancer (NSCLC), a leading cause of cancer deaths, represents a heterogeneous group of neoplasms, mostly comprising squamous cell carcinoma (SCC), adenocarcinoma (AC) and large-cell carcinoma (LCC). The objectives of this study were to utilize integrated genomic data including copy-number alteration, mRNA, microRNA expression and candidate-gene full sequencing data to characterize the molecular distinctions between AC and SCC.,Comparative genomic hybridization followed by mutational analysis, gene expression and miRNA microarray profiling were performed on 123 paired tumor and non-tumor tissue samples from patients with NSCLC.,At DNA, mRNA and miRNA levels we could identify molecular markers that discriminated significantly between the various histopathological entities of NSCLC. We identified 34 genomic clusters using aCGH data; several genes exhibited a different profile of aberrations between AC and SCC, including PIK3CA, SOX2, THPO, TP63, PDGFB genes. Gene expression profiling analysis identified SPP1, CTHRC1 and GREM1 as potential biomarkers for early diagnosis of the cancer, and SPINK1 and BMP7 to distinguish between AC and SCC in small biopsies or in blood samples. Using integrated genomics approach we found in recurrently altered regions a list of three potential driver genes, MRPS22, NDRG1 and RNF7, which were consistently over-expressed in amplified regions, had wide-spread correlation with an average of ~800 genes throughout the genome and highly associated with histological types. Using a network enrichment analysis, the targets of these potential drivers were seen to be involved in DNA replication, cell cycle, mismatch repair, p53 signalling pathway and other lung cancer related signalling pathways, and many immunological pathways. Furthermore, we also identified one potential driver miRNA hsa-miR-944.,Integrated molecular characterization of AC and SCC helped identify clinically relevant markers and potential drivers, which are recurrent and stable changes at DNA level that have functional implications at RNA level and have strong association with histological subtypes.

文献信息
期刊
BMC medical genomics
期刊简称
BMC Med Genomics
发表日期
2014-06-25
收录日期
2013-12-10
更新日期
2015-04-22
语言
英语
国家/地区
England
NLM ID
101319628
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com